See our latest analysis for Moog.
Moog’s share price has seen mixed action recently, with a modest 1.76% gain over the past month and a strong 9.57% share price return in the last 90 days. Combined with its 7.23% total shareholder return over the past year and an impressive 245.8% over five years, the momentum appears solid and suggests investors are rewarding the company’s strengthening fundamentals.
If you’re curious where other defense and aerospace names are showing similar strength this year, it’s worth checking out See the full list for free.
With shares trading about 12 percent below the average analyst price target and profits rising much faster than sales, the question is whether Moog is now undervalued or if the market has already accounted for stronger growth ahead.
Most Popular Narrative: 11% Undervalued
Moog's narrative valuation points to a fair value significantly above the last close, with analysts projecting a stronger outlook for growth and profits. This view contrasts the company’s recent price action and positions the stock as a potential upside story.
Moog is positioned to benefit from a sustained increase in global defense spending, with significant order backlog and direct exposure to U.S., NATO, and Indo-Pacific modernization programs, which is likely to drive multi-year revenue growth and increased earnings stability.
Curious about the financial formula behind this bullish narrative? The secret lies in aggressive profit margin targets and ambitious revenue expansion, figures usually reserved for the sector's fastest climbers. Want to see what gives analysts the confidence to call for a much higher valuation? Dive into the full details and see what the consensus expects Moog to achieve.
Result: Fair Value of $228.75 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, persisting supply chain disruptions or unexpected cuts to global defense budgets could quickly challenge the positive outlook that is currently supporting Moog's valuation.
Find out about the key risks to this Moog narrative.
Another View: Discounted Cash Flow Perspective
While the narrative-based valuation pegs Moog as undervalued, our DCF model suggests a different story. According to Simply Wall St’s discounted cash flow calculation, Moog is actually trading above its estimated fair value. This could indicate the shares are already priced for optimistic growth. Does this mean investors are placing too much faith in future earnings, or could DCF be missing key catalysts?
Look into how the SWS DCF model arrives at its fair value.
Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Moog for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover undervalued stocks based on their cash flows. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.
Build Your Own Moog Narrative
If you see things differently or want to dig into the numbers yourself, you can craft a personalized narrative with just a few clicks. Do it your way
A great starting point for your Moog research is our analysis highlighting 4 key rewards and 1 important warning sign that could impact your investment decision.
Looking for more investment ideas?
Seize your chance to invest smarter by tapping into thematic stock lists built to spot tomorrow’s big winners before the crowd does. Don’t let unique opportunities slip by. Try these screens today:
- Maximize your potential for outsized gains by targeting fast-growing businesses among these 3575 penny stocks with strong financials with solid fundamentals and compelling momentum.
- Lock in reliable income and boost your portfolio’s stability as you browse these 17 dividend stocks with yields > 3% featuring top picks with attractive yields exceeding 3%.
- Ride the forefront of healthcare innovation by exploring these 33 healthcare AI stocks, where AI-driven companies are transforming patient care and diagnostics.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Valuation is complex, but we're here to simplify it.
Discover if Moog might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com